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Introduction: Infantile myoﬁbroma (IM) is a benign mesenchymal disorder. Although it is
the most common tumor of infancy, it is a relatively rare pathological entity. IM occurs
predominantly before the age of two. It is characterized by tumor formation in skin,
muscle, viscera, bone and subcutaneous tissues. The tumor can occur in either solitary or
multicentric forms. The solitary form without visceral involvement usually has a benign
course. Male gender predominates in the solitary form.
Case presentation: We report a clinical case of an osseous infantile myoﬁbroma of the
zygomatico-maxillo-orbital complex in a 4 months old male. We also show the radiological
spontaneous regression without surgical intervention. Clinical, radiological, and histo-
pathological examinations established the diagnosis. Our treatment was conservative with
clinical follow-up. No surgical intervention was carried out during the course of the dis-
ease. Signiﬁcant spontaneous regression occurred after a year and was conﬁrmed by CT
scan.
Conclusion: Radiologically aggressive infantile myoﬁbroma has been previously treated by
surgical intervention. In this case report there was a signiﬁcant spontaneous regression.
Conservative treatment and follow-up may be an appropriate alternative.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Infantile myoﬁbroma is a benign mesenchymal tumor of infancy. It is characterized by tumor formation in skin, muscle,
viscera, bone and subcutaneous tissue [11]. This tumor affects exclusively infants. Eighty-eight percent of the cases occurred
before the age of two. Solitary forms have a male predominance [3]. One third of the cases involve the head and neck region.
The clinical heterogeneity and misleading histopathological appearance make the diagnosis difﬁcult [8]. The oldest re-
ported patient that presented with “infantile” myoﬁbroma was 49 year-old female reported by Wolfe [13]. Foss reported 79
cases of myoﬁbroma with different patterns including infantile or adult, and multicentric or solitary. The patients' ages at
diagnosis ranged from birth to 84 years [5]. In his series the oldest patient was not clearly identiﬁed as an “infantile” myo-
ﬁbroma. All tumors are positive for vementin and alpha-smoothmuscle actin [7]. We share our experiencewith a unique casement of Plastic Surgery, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden.
now).
vier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
K. Arab et al. / Oral and Maxillofacial Surgery Cases 2 (2016) 35e3936of infantile myoﬁbroma of the zygomatico-maxillo-orbital complex that spontaneously regressed without any surgical
intervention, sparing the child from tumor extirpation as well as reconstructive procedures despite the large size of the
tumor.
2. Case report
We describe a case of a male child bornwith uneventful vaginal delivery with normal Apgar score and no complications at
birth. This boy was referred to the pediatrician at the age of 4 months because of progressive swelling of the right cheek with
ectropion of the lower eyelid. The differential diagnoses of this swelling included: hemangioma, vascular malformation,
leiomyoma, rhabdomyosarcoma and osseous benign ormalignant tumors. An ultrasound detected amass of 28 30 20mm
at the level of zygomatic bone.
AnMRI and a CT scanwere performed and showed a 27 28 22mmmass in the right zygomatic bonewith erosions and
an expanding osseous tumor beyond the normal borders of the zygoma involving the zygomatico-maxillo-orbital complex
(Figs. 1 and 2).
A needle biopsy was performed and showed benign myoﬁbroblastic proliferation with osseous involvement and
conﬁrmed the diagnosis of infantile myoﬁbroma (Fig. 3).
At the age of 8 months our craniofacial team received a referral from a pediatric ENT surgeon. On physical examination, the
mass was slightly tender but no further increase in swelling was noted. There was no involvement of facial musculature.
Extra-ocular muscles and ophthalmological evaluation were normal. No intra-oral lesions were present. The occlusion was
normal and airway was patent. No other lesions identiﬁed. At that time surgery was preliminary scheduled but a CT scan was
ordered for further evaluation and treatment planning. The new CT scan demonstrated a signiﬁcant reduction of tumor size to
20  20  17 mmwith increased mineralization of the tumor borders. At that stage surgical interventionwas abandoned and
the patient was followed up in the clinic (Fig. 4).
Clinical evaluation 6 months later showed further reduction of the mass. CT scan at 2 years and 5 month of age showed
further reduction of the size of the tumor (13  10  10 mm) with additional mineralization and remodeling of the
zygomatico-maxillo-orbital complex towards the normal anatomy (Fig. 5).
3. Discussion
Bone masses and osseous lesions in infancy can be challenging to diagnose. Differential diagnoses can include benign or
malignant tumors, which need to be treated differently. The correlation between clinical and histological examination is
essential for accurate diagnosis and treatment.
Stout initially described infantile myoﬁbroma in 1954. He termed the disorder “congenital generalized ﬁbromatosis” [15].
Infantile myoﬁbroma (IM) is an extremely rare tumor although considered themost common tumor of infancy. Chung and
Enzinger evaluated infantile myoﬁbroma and concluded that 60% of the cases were noted at birth or shortly thereafter.Fig. 1. MRI at 10 months of age showing the tumor, 27  28  22 mm in size.
Fig. 2. 3D CT at 10 months of age showing tumor destruction of right zygoma.
Fig. 3. Histopathology shows bundles of myoﬁbroblast cells compatible with the diagnosis of infantile myoﬁbroma.
Fig. 4. Coronal CT scan at 15 months of age showing a minor decrease in size and mineralization of outer borders.
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Fig. 5. 3D CT at 2 years 5 months of age showing further regression and mineralization of zygomatic bone regaining its normal anatomic shape.
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with IM. Patients withmulticentric form of the disorder and visceral involvement had aworse prognosis and highermortality
[11].
In general, myoﬁbromatosis can be classiﬁed into three categories. The solitary form appears at birth or later with a three
to one male predominance. These tumors are usually located in the skin or soft tissue and have rarely been reported in bone.
The second form is multicentric. It is usually congenital and has a one to two female predominance. In addition to skin and
soft tissue, this type appears in bone. These two forms are usually treated surgically when locally aggressive or obstructive [1].
They usually have favorable prognosis and very low mortality rate [14]. The third form is the generalized form with visceral
involvement. Chemotherapymay be indicated in the later [2,4,9]. This form has the worse prognosis with seventy-six percent
of the cases died at birth or soon after [12]. Lung or central nervous central system involvement carries the worst prognosis
[10].
Fukasawa and his colleagues proposed that these tumors underwent central massive apoptosis that may lead to spon-
taneous regression [6]. However, the natural history of infantile myoﬁbroma is not known. The sizes of these tumors seem to
be small to moderate. Extirpation with narrow margins is often the treatment of choice. Our case report may advocate for a
more conservative approach, avoiding unnecessary surgery in children.
One cannot change clinical recommendations from a single case report, but we hope for more data collection regarding
growth, time course and possible spontaneous regression of infantile myoﬁbroma.
4. Conclusion
Our patient reported in this paper was diagnosed with infantile myoﬁbroma of the zygomatico-maxillo-orbital complex.
In this case, we demonstrate the clinical and radiological regression of this benign tumor without any surgical intervention.
We believe that a conservative approach towards these tumors should be considered more often to avoid unnecessary
surgical intervention. Further studies of conservative treatment and the time course of possible tumor regression are
encouraged.
Consent
Written informed consent was obtained from both parents.
Conﬂict of interest statement
The authors report no conﬂicts of interest according to this case report.References
[1] Behar PM, Albritton FD, Muller S, Todd NW. Multicentric infantile myoﬁbromatosis. Int J Pediatr Otorhinolaryngol 1998;45(3):249e54.
[2] Rubin BO, Bridge JA. Myoﬁbroma/myoﬁbromatosis. In: Fletcher CD, Unni KK, Mertens F, editors. WHO classiﬁcation of tumors, pathology and genetics.
Tumors of soft tissue and bone. Lyon, France: IARC Press; 2002. p. 59e61.
[3] Chung EB, Enzinger FM. Infantile myoﬁbromatosis. Cancer 1981;48:1807e18.
[4] Fibrous tumors of infancy and childhood. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss's soft tissue tumors. St Louis, Miss, USA: Mosby;
2001a. p. 347e408.
[5] Foss RD, Ellis GL. Myoﬁbromas and myoﬁbromatosis of the oral region: a clinicopathological analysis of 79 cases. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2000;89(1):57e65.
[6] Fukasawa Y, Ishikura H, Takada A, Yokoyama S, Imamura M, Yoshiki T, et al. Massive apoptosis in infantile myoﬁbromatosis. A putative mechanism of
tumor regression. Am J Pathol 1994;144:480e5.
K. Arab et al. / Oral and Maxillofacial Surgery Cases 2 (2016) 35e39 39[7] Lopes RN, Alves Fde A, Rocha AC, Suassuna TM, Kowalski LP, de Castro JF, et al. Head and neck solitary infantile myoﬁbroma: clinicopathological and
immunohistochemical features of a case series. Acta Histochem 2015;117(4e5):431e6.
[8] Loundon N, Dedieuleveult T, Ayache D, Roger G, Josset P, Garabedian EN. Head and neck infantile myoﬁbromatosisd a report of three cases. Int J
Pediatr Otorhinolaryngol 1999;51:181e6.
[9] Myoﬁbroma and myoﬁbromatosis. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss's soft tissue tumors. St Louis, Miss, USA: Mosby; 2001b. p.
357e63.
[10] Netscher DT, Eladoumikdachi F, Popek EJ. Infantile myoﬁbromatosis: case report of a solitary had lesion with emphasis on differential diagnosis and
management. Ann Plast Surg 2001;46(1):62e7.
[11] Wiswell TE, Davis J, Cunningham BE, Solenberger R, Thomas PJ. Infantile myoﬁbromatosis: the most common ﬁbrous tumor of infancy. J Pediatr Surg
1988;23:315e8.
[12] Wiswell TE, Sakas EL, Stephenson SR, Lesica JJ, Reddoch SR. Infantile myoﬁbromatosis. Pediatrics 1985;76(6):981e4.
[13] Wolfe 3rd JT, Cooper PH. Solitary cutaneous “infantile” myoﬁbroma in a 49-year-old woman. Hum Pathol 1990;21(5):562e4.
[14] Zeller B, Strom-Mathisen I, Smevik B, Sund S, Danielsen K, Lie SO. Cure of infantile myoﬁbromatosis with severe respiratory complications without
antitumour therapy. Eur J Pediatr 1997;156(11):841e4.
[15] Stout AP. Juvenile ﬁbromatoses. Cancer 1954;7:953e78.
